These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30146228)

  • 1. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
    Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
    Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
    Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.
    Xu B; Chen Y; Guo Y; Zhou D; Yue Z; Duan Q; Yang Y; Guan G; Chi P; Lin C
    Am J Clin Oncol; 2018 Jun; 41(6):601-606. PubMed ID: 27672742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002).
    Wang J; Guan Y; Gu W; Yan S; Zhou J; Huang D; Tong T; Li C; Cai S; Zhang Z; Zhu J
    Radiat Oncol; 2019 Nov; 14(1):215. PubMed ID: 31783766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study.
    Bergquist JR; Thiels CA; Shubert CR; Habermann EB; Hayman AV; Zielinski MD; Mathis KL
    World J Surg; 2016 Feb; 40(2):447-55. PubMed ID: 26566779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis.
    Worrell SG; Towe CW; A Dorth J; Machtay M; Perry Y; Linden PA
    Ann Surg Oncol; 2020 Feb; 27(2):500-508. PubMed ID: 31571054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
    Cassidy RJ; Liu Y; Patel K; Zhong J; Steuer CE; Kooby DA; Russell MC; Gillespie TW; Landry JC
    Cancer; 2017 Mar; 123(5):783-793. PubMed ID: 27780316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer.
    Yaghobi Joybari A; Azadeh P; Babaei S; Hosseini Kamal F
    Pathol Oncol Res; 2019 Oct; 25(4):1599-1605. PubMed ID: 30712194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study.
    Bosch SL; Verhoeven RHA; Lemmens VEPP; Simmer F; Poortmans P; de Wilt JHW; Nagtegaal ID
    Virchows Arch; 2019 Dec; 475(6):745-755. PubMed ID: 31463728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
    Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J
    J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
    Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer.
    Natesan D; Hong JC; Foote J; Sosa JA; Havrilesky L; Chino J
    Int J Gynecol Cancer; 2017 May; 27(4):794-804. PubMed ID: 28333840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
    Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
    Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response.
    Gahagan JV; Whealon MD; Phelan MJ; Mills S; Jafari MD; Carmichael JC; Stamos MJ; Zell JA; Pigazzi A
    Surg Oncol; 2020 Mar; 32():35-40. PubMed ID: 31726418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.
    Wells SM; Boothe D; Ager BJ; Tao R; Gilcrease GW; Lloyd S
    Clin Colorectal Cancer; 2020 Jun; 19(2):91-99.e1. PubMed ID: 32173281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
    Maeda K; Shibutani M; Tachimori A; Nishii T; Aomatsu N; Fukuoka T; Nagahara H; Otani H; Inoue T; Ohira M
    In Vivo; 2020; 34(1):283-289. PubMed ID: 31882490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
    Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
    Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
    Lee WC; Yusof MM; Lau FN; Phua VC
    Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.